Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 and chemosensitivity in bladder cancer.

International journal of clinical oncology - 1 Aug 2008

Nishiyama Hiroyuki, Watanabe Jun, Ogawa Osamu

Abstract excerpt

Urothelial carcinoma is the second most common genitourinary malignancy. Although the majority of patients present with superficial bladder tumors, there are several clinical problems, such as progression to invasive tumors, poor prognosis of invasive tumors, and chemosensitivity. Alterations in p53 represent one of the most common genetic events in patients with invasive urothelial carcinoma and are suggested to...

Topics

Apoptosis
Carcinoma, Transitional Cell
Disease Progression
Drug Resistance, Neoplasm
Genes, p53
Humans
Mutation
Urinary Bladder Neoplasms

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18704627
DOI: 10.1007/s10147-008-0815-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 and chemosensitivity in bladder cancer.PMID 18704627Read ↗

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.Semantic proximity Read ↗

p53 and retinoblastoma pathways in bladder cancer.Semantic proximity Read ↗

Tp53 and its potential therapeutic role as a target in bladder cancerSemantic proximity Read ↗

p53 and treatment of bladder cancer.Semantic proximity Read ↗

Mutation of cell cycle regulators and their impact on superficial bladder cancer.Semantic proximity Read ↗

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.Semantic proximity Read ↗

Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.Semantic proximity Read ↗

p53 regulation of DNA excision repair pathways.Semantic proximity Read ↗

Significance of TP53 mutation in bladder cancer disease progression and drug selectionSemantic proximity Read ↗

Response of the Urothelial Carcinoma Cell Lines to CisplatinSemantic proximity Read ↗

Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.Semantic proximity Read ↗

Prima-1 induces apoptosis in bladder cancer cell lines by activating p53.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.